BY WILLIAM M. ABR AHAM AND DANIEL G. BADEN WHERE WE WERE
Reports of airway irritant eff ects from Florida red tide have been documented since 1844 . In general, it is well established that persons inhaling marine aerosols containing polyether brevetoxins (PbTxs) produced by the dinofl agellate, Karenia brevis (K. brevis), can exhibit either upper and/or lower airway symptoms (see Backer and McGillicuddy, this issue) . Upper-airway symptoms include cough, sneezing, rhinorrhea (runny nose), a burning sensation in the nose and throat, and watery eyes (Kirkpatrick et al., 2004) . Lowerairway symptoms include chest tightness and wheezing and/or shortness of breath, all of which refl ect diffi culty in breathing (Kirkpatrick et al., 2004) . Normal individuals, as well as those with pre-existing airway diseases such as asthma (i.e., susceptible populations), can be aff ected, although anecdotal evidence has indicated that susceptible populations are at greater risk (Asai et al., 1982) .
While such accounts leave little doubt that aerosolized red tides can elicit adverse airway responses, until recently there was a void in our knowledge due to the inability to accurately quantify exposure assessment and associate the exposure with pulmonary consequences. Furthermore, there was a paucity of data detailing the mechanisms responsible for the adverse pulmonary events. To rectify this problem, an interdisciplinary group of scientists has engaged in studies that combine analytical marine natural products chemistry, quantitative air sampling, laboratory model studies of inhalation exposure, and human exposure and health assessment in areas of active red tide (Fleming et al., 2005a) .
WHERE WE ARE
Data from fi eld studies indicate that the severity of the pulmonary responses to aerosolized Florida red tide is dependent on the combined interaction of the total air toxin load, the specifi c toxins aerosolized, and the particle size of these airborne toxins. We have learned that the total air toxin load is dependent not only on the cell counts of K. brevis in the water, but also on the wind speed and the fraction of the time the wind is in the onshore direction . Th us, high-water cell counts in the presence of off shore winds, resulting in minimal onshore aerosol exposures, can explain why no observable airway eff ects occur even with signifi cant oceanic blooms of Florida red tide.
Currently, there are 12 known PbTx's produced by K. brevis . Analysis of aerosols during diff erent Florida red tide episodes indicate that PbTx-2, PbTx-3, and two metabolites PbTx-9 and PbTx-carboxylic acid (PbTx-ca), are the major toxins found in collected air samples ; D.G.
Baden, University of North Carolina, Wilmington, personal communication, 2006) . Figure 1 provides the chemical structures and compares the relative constrictor eff ects of equivalent amounts of these toxins in a large animal model of asthma (Abraham et al., 2005a) . As can be seen, PbTx-2 and PbTx-3 are the major toxins responsible for the constrictor eff ects of aerosolized Florida red tide. Th e decomposition products are less active than the primary toxins but are still potent enough to contribute to the airway irritant eff ects.
Such structure-function studies are important for understanding the mechanisms involved in toxin-induced airway eff ects. Furthermore, they are highly pertinent because they are conducted with environmentally relevant concentrations of individual toxigenic agents and/or natural brevetoxins (Abraham et al., 2005a . To complicate matters further, K. brevis also produces its own natural antagonist-brevenal (Bourdelais et al., 2004) .
Brevenal has been identifi ed in collected fi eld air samples , and when aerosolized, brevenal can block the constrictor effects of crude brevetoxins, PbTx-2, and PbTx-3 (Abraham et al., 2005a) . Th us, the relative concentrations of the toxins and antagonist will infl uence the overall pulmonary eff ect of an aerosol exposure, another reason why some Florida red tide blooms have greater respiratory eff ects than do others.
Finally, even though there may be a significant toxin aerosol burden, the particle size of the toxin will determine the major site of action. Cheng et al. (2005) found that only 2-6 percent of the aerosolized toxin was suffi ciently small (i.e., the respirable fraction) to allow eff ective deposition in the pulmonary (Abraham et al., 2005a) . Th is latter eff ect, similar to the airway constrictor ef- (Benson et al., 2005) , and sheep inhaling brevetoxin for four days showed decreased lung macrophage function . Both of these responses would be consistent with increased incidence of disease. Further studies will be necessary to confi rm these observations and identify the mechanisms responsible.
Animal studies have not only been useful in identifying potential harmful eff ects of toxin, but also have provided some data on the medications that can prevent and/or reverse the airway eff ects of Florida red tide . While confi rmation of these results must await clinical trials, anecdotal evidence for the use of bronchodilators and antihistamines to treat and/or prevent the symptoms in humans support the laboratory fi ndings (Fleming et al., 2005b) .
Finally, the discovery of brevenal, the natural brevetoxin antagonist, has not only led to studies designed to counteract the eff ects of brevetoxin, but also to the discovery that this agent may have potential therapeutic value in combating airway diseases such as cystic fi brosis and chronic obstructive lung disease (Abraham et al., 2005a) . As such, brevenal and/or other toxin congeners will be the focus of ongoing research. Toward this goal, the recent availability of radio-labeled brevenal provides a new potential probe for identifying drug targets in the airways.
